Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease

Published:2016-10-12 Issue:1 Volume:65 Page:65-77
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Ajmera Veeral¹,Perito Emily R.²,Bass Nathan M.¹,Terrault Norah A.¹,Yates Katherine P.³,Gill Ryan⁴,Loomba Rohit⁵,Diehl Anna Mae⁶,Aouizerat Bradley E.⁷,

Affiliation:

1. Division of Gastroenterology andUniversity of California‐San FranciscoSan Francisco CA

2. Division of Pediatric GastroenterologyUniversity of California‐San FranciscoSan Francisco CA

3. Department of EpidemiologyJohns Hopkins Bloomberg School of Public HealthBaltimore MD

4. Division of PathologyUniversity of California‐San FranciscoSan Francisco CA

5. Division of GastroenterologyUniversity of California‐San DiegoSan Diego CA

6. Division of GastroenterologyDuke UniversityDurham NC

7. Bluestone Center for Clinical ResearchNew York UniversityNew York City NY

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.28776

Reference57 articles.

1. Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study

2. Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆

3. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

4. The Role of Cytokines in Non-Alcoholic Fatty Liver Disease

5. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD;Seminars in Liver Disease;2024-07-11

2. Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease;Alimentary Pharmacology & Therapeutics;2024-07-03

3. Proinflammatory interleukins 2, 6 and tumor necrosis factor alpha in patients with hypertension and diabetes mellitus depending on the presence of metabolic-associated liver steatosis;INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine);2024-06-27

4. The Role of Fibrinolytic Activity of Blood Plasma in the Development of Obstetric Complications in Overweight Pregnant Women with Metabolic Dysfunction-Associated Steatohepatitis: A Prospective Cohort Study;Clinical and Experimental Obstetrics & Gynecology;2024-05-15

5. Correlation of alanine aminotransferase levels and a histological diagnosis of steatohepatitis with ultrasound-diagnosed metabolic-associated fatty liver disease in patients from a centre in Nigeria;BMC Gastroenterology;2024-05-09